Tirzepatide (30 mg)

What is Tirzepatide (30mg)?

Tirzepatide (30mg) is a synthetic peptide in the category of multi-hormone receptor agonist peptides. Composed of 39 amino acids, it features structural modifications, including non-standard amino acids and a lipid-linked side chain, to enhance stability and biological activity in experimental models.

• Chemical Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.48 g/mol
• CAS Number: 2023788-19-2

The peptide sequence includes modified residues, such as Aib (α-aminoisobutyric acid) and a fatty-acid-linked lysine, which may impact peptide behavior in laboratory systems. Research-grade Tirzepatide is typically produced with high purity, verified by high-performance liquid chromatography (HPLC) and mass spectrometry (MS). In scientific studies, it is primarily researched for its role in metabolic hormone signaling pathways.

What are the key features of Tirzepatide (30mg)?

• Synthetic peptide composed of 39 amino acids
• High analytical purity verified by HPLC and MS
• Supplied as a 30 mg lyophilized powder in a sealed research-grade vial
• Studied in metabolic hormone signaling and endocrine pathway research
• Approximate 24-month shelf life when stored under recommended conditions
• For laboratory research use only

How is Tirzepatide (30mg) synthesized?

Tirzepatide (30mg) is produced using solid-phase peptide synthesis (SPPS), a standard technique for constructing peptides with precise amino acid sequences. During this process, individual amino acids are sequentially attached to a growing peptide chain anchored to a solid support. After synthesis, purification is performed with high-performance liquid chromatography (HPLC) to ensure high purity suitable for research. Structural verification and molecular weight confirmation are conducted using mass spectrometry (MS). The peptide is then lyophilized to enhance stability and facilitate long-term storage under controlled laboratory conditions.

What is Tirzepatide (30mg) being studied for? What are its possible benefits?

In laboratory research, Tirzepatide (30mg) has been studied in experimental models related to metabolic regulation and endocrine signaling. Peptides in this class are often examined for their role in hormone-related communication systems that regulate energy balance and metabolic activity. Research areas involving Tirzepatide include:

• Metabolic hormone signaling
• Energy balance and nutrient regulation
• Endocrine pathway investigations
• Experimental metabolic and endocrine models
• Glucose metabolism and hormonal communication

Although experimental studies suggest that peptides affecting metabolic hormone pathways may influence nutrient processing and energy homeostasis, these findings are still under investigation and should not be considered as therapeutic outcomes.

How does Tirzepatide (30mg) work in research studies?

In laboratory studies, Tirzepatide (30mg) is investigated for its ability to interact with cellular signaling pathways involved in metabolic hormone regulation. Multi-receptor peptides are designed to influence biological systems that coordinate nutrient metabolism and endocrine communication. Researchers are studying how this peptide may affect intracellular signaling pathways that regulate energy metabolism and hormone signaling in experimental models. These mechanisms are under active research and exploration.

What dosing information exists for Tirzepatide (30mg)?

Research involving Tirzepatide (30mg) has been conducted primarily in preclinical experimental models, such as cellular studies and animal research. In vitro experiments typically examine the peptide at nanomolar to micromolar concentrations to observe cellular responses related to metabolic signaling. Animal studies on similar metabolic peptides have reported dosing ranges in the microgram per kilogram (µg/kg) scale, depending on the research objective and biological model. Since Tirzepatide is a research compound, there are no standardized human dosing guidelines for its use in laboratory investigations.

How should Tirzepatide (30mg) be stored and handled?

Tirzepatide (30mg) should be stored under controlled laboratory conditions to maintain peptide stability. Recommended storage conditions are 2–8 °C for routine storage, while ≤–20 °C is suitable for long-term preservation when the peptide is not in use. The lyophilized powder should be kept away from light, heat, and moisture to prevent degradation. If reconstituted with a sterile laboratory-grade solvent, the solution should be stored at 2–8 °C for short-term use. Avoid repeated freeze–thaw cycles, as they may affect peptide integrity. When stored properly, the peptide typically maintains stability for up to 24 months.

Where can I read more research about Tirzepatide (30mg)?

Researchers interested in metabolic peptide signaling and Tirzepatide-related studies may consult the following scientific publications:

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 156588324, Tirzepatide. https://pubchem.ncbi.nlm.nih.gov/compound/156588324
2. Sun B, Willard FS, Feng D, et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc Natl Acad Sci U S A. 2022;119(13):e2116506119. doi:10.1073/pnas.2116506119
3. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018;18:3-14. doi:10.1016/j.molmet.2018.09.009
4. Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules. 2022;27(13):4315. Published 2022 Jul 5. doi:10.3390/molecules27134315
5. Tirzepatide: Uses, interactions, mechanism of action. DrugBank. https://go.drugbank.com/drugs/DB15171

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.